BrightView Holdings, Inc.
NYSEBV heads into the back half of 2026 with a fresh analyst endorsement landing the same week shorts have been steadily rebuilding — a mild tension in an otherwise quiet story. The most notable event this week was Oppenheimer's initiation this morning. Scott Schneeberger opened coverage with an Outperform rating and a $17 target, above the $16.68 consensus mean. That follows a…
Snapshot as of 27 Jun 2026
BV heads into the back half of 2026 with a fresh analyst endorsement landing the same week shorts have been steadily rebuilding — a mild tension in an otherwise quiet story. The most notable event this week was…
BV reported Q2 fiscal 2026 results on May 5th — and the print was a split verdict. Revenue topped estimates and full-year guidance moved higher, but EPS came in light. That combination explains the week: the stock…
BV heads into its fiscal Q2 2026 earnings call today with a mixed print already on the tape: revenue blew past estimates, but the bottom line fell short. The headline numbers split neatly between top and bottom.…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BV — free to start on ORTEX.
Sign up for free →Open BV on ORTEX